Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, Johns DG, Woods TN, Doe CP, Coatney RW, Ohlstein JF, Douglas SA, Willette RN, Yue TL.
Bao W, et al. Among authors: mirabile rc.
J Cardiovasc Pharmacol. 2007 Jun;49(6):362-8. doi: 10.1097/FJC.0b013e318046f34a.
J Cardiovasc Pharmacol. 2007.
PMID: 17577100